Literature DB >> 35980512

Role of empirical isolation of the superior vena cava in patients with recurrence of atrial fibrillation after pulmonary vein isolation-a multi-center analysis.

Sven Knecht1,2, Ivan Zeljkovic3, Michael Kühne4,5, Christian Sticherling4,5, Patrick Badertscher4,5, Philipp Krisai4,5, Florian Spies4,5, Jan Vognstrup4, Nikola Pavlovic6, Sime Manola6, Stefan Osswald4,5.   

Abstract

BACKGROUND: Non-pulmonary vein (PV) triggers play a role in the initiation of atrial fibrillation (AF), with the superior vena cava (SVC) being a common location. The aim of the current study was to investigate a strategy of empirical SVC isolation (SVCI) in addition to re-isolation of PV in patients with recurrence of AF after index PV isolation (PVI).
METHODS: We retrospectively analyzed consecutive patients from two centers with recurrence of AF after index PVI, undergoing a repeat ablation. Whereas only a re-isolation of the PV was intended in patients with reconnections of equal or more than two PV (PVI group), an additional SVCI was aimed for in patients with < 2 isolated PV in addition to the re-isolation of the PV (PVI + group). Analysis was performed as-treated and per-protocol.
RESULTS: Of the 344 patients included in the study (age 60 ± 10 years, 73% male, 66% paroxysmal AF), PVI only was performed in 269 patients (77%) and PVI plus SVCI (PVI +) in 75 patients (23%). Overall, freedom from AF/AT after repeat PVI was 80% (196 patients) in the PVI group and 73% in the PVI + group (p = 0.151). In multivariable Cox regression analysis, presence of persistent AF (HR 2.067 (95% CI 1.389-3.078), p < 0.001) and hypertension (HR 1.905 (95% CI 1.218-2.980), p = 0.005) were identified as only significant predictors of AF/AT recurrence. The per-protocol results did not differ from this observation.
CONCLUSIONS: A strategy of an empirical additional SVCI at repeat PVI ablation for recurrence of AF/AT does not improve outcome compared to a PVI only approach.
© 2022. The Author(s).

Entities:  

Keywords:  Atrial fibrillation; Isolation; Pulmonary vein isolation; Recurrence; Repeat; Superior vena cava

Year:  2022        PMID: 35980512     DOI: 10.1007/s10840-022-01314-w

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.759


  21 in total

1.  Remote-controlled magnetic pulmonary vein isolation combined with superior vena cava isolation for paroxysmal atrial fibrillation: a prospective randomized study.

Authors:  Antoine Da Costa; Marie Levallois; Cécile Romeyer-Bouchard; Laurence Bisch; Alexis Gate-Martinet; Karl Isaaz
Journal:  Arch Cardiovasc Dis       Date:  2015-02-07       Impact factor: 2.340

2.  Prevalence and distribution of focal triggers in persistent and long-standing persistent atrial fibrillation.

Authors:  Pasquale Santangeli; Erica S Zado; Mathew D Hutchinson; Michael P Riley; David Lin; David S Frankel; Gregory E Supple; Fermin C Garcia; Sanjay Dixit; David J Callans; Francis E Marchlinski
Journal:  Heart Rhythm       Date:  2015-10-23       Impact factor: 6.343

3.  Idiopathic paroxysmal atrial fibrillation induced by a focal discharge mechanism in the left superior pulmonary vein: possible roles of the ligament of Marshall.

Authors:  C Hwang; H S Karagueuzian; P S Chen
Journal:  J Cardiovasc Electrophysiol       Date:  1999-05

4.  Impact of systematic isolation of superior vena cava in addition to pulmonary vein antrum isolation on the outcome of paroxysmal, persistent, and permanent atrial fibrillation ablation: results from a randomized study.

Authors:  Andrea Corrado; Aldo Bonso; Michela Madalosso; Antonio Rossillo; Sakis Themistoclakis; Luigi Di Biase; Andrea Natale; Antonio Raviele
Journal:  J Cardiovasc Electrophysiol       Date:  2009-09-01

5.  Left atrial appendage: an underrecognized trigger site of atrial fibrillation.

Authors:  Luigi Di Biase; J David Burkhardt; Prasant Mohanty; Javier Sanchez; Sanghamitra Mohanty; Rodney Horton; G Joseph Gallinghouse; Shane M Bailey; Jason D Zagrodzky; Pasquale Santangeli; Steven Hao; Richard Hongo; Salwa Beheiry; Sakis Themistoclakis; Aldo Bonso; Antonio Rossillo; Andrea Corrado; Antonio Raviele; Amin Al-Ahmad; Paul Wang; Jennifer E Cummings; Robert A Schweikert; Gemma Pelargonio; Antonio Dello Russo; Michela Casella; Pietro Santarelli; William R Lewis; Andrea Natale
Journal:  Circulation       Date:  2010-07-06       Impact factor: 29.690

6.  A histological study of the cardiac muscle of the human superior and inferior venae cavae.

Authors:  H Hashizume; T Ushiki; K Abe
Journal:  Arch Histol Cytol       Date:  1995-10

7.  Pulmonary vein isolation combined with superior vena cava isolation for atrial fibrillation ablation: a prospective randomized study.

Authors:  Xin-Hua Wang; Xu Liu; Yu-Min Sun; Hai-Feng Shi; Li Zhou; Jia-Ning Gu
Journal:  Europace       Date:  2008-05       Impact factor: 5.214

8.  The mechanisms of recurrent atrial arrhythmias after second-generation cryoballoon ablation.

Authors:  Shinsuke Miyazaki; Tomoki Horie; Hitoshi Hachiya; Kanae Hasegawa; Takatsugu Kajiyama; Tomonori Watanabe; Hiroaki Nakamura; Eri Ishikawa; Moe Mukai; Daisetsu Aoyama; Minoru Nodera; Kenichi Kaseno; Yoshito Iesaka; Hiroshi Tada
Journal:  Am Heart J       Date:  2019-12-16       Impact factor: 4.749

9.  Non-Pulmonary Vein Triggers of Atrial Fibrillation Are Likely to Arise from Low-Voltage Areas in the Left Atrium.

Authors:  Shunsuke Kawai; Yasushi Mukai; Shujiro Inoue; Daisuke Yakabe; Kazuhiro Nagaoka; Kazuo Sakamoto; Susumu Takase; Akiko Chishaki; Hiroyuki Tsutsui
Journal:  Sci Rep       Date:  2019-08-22       Impact factor: 4.379

10.  Pulmonary vein reconnection predicts good clinical outcome after second catheter ablation for atrial fibrillation.

Authors:  Tae-Hoon Kim; Junbeom Park; Jae-Sun Uhm; Boyoung Joung; Moon-Hyoung Lee; Hui-Nam Pak
Journal:  Europace       Date:  2017-06-01       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.